Ventricular Tachycardia Cohort

N/ANot Yet RecruitingNCT07149701

Beijing Anzhen Hospital1,500 enrolled

Overview

The goal of this observational study is to detect the long-term risk of a composite endpoint event in adult patients with ventricular tachycardia (VT) who are managed with catheter ablation or non-ablation management (including modern drug therapy and/or ICD therapy).

Study Type

OBSERVATIONAL

Enrollment

1,500

Conditions

Ventricular Tachycardia (VT)

Interventions

InterventionDEVICE

Treatment with intervention of catheter ablation or Implantable cardioverter defibrillator.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Sustained ventricular tachycardia (VT), defined as VT lasting ≥30 seconds or requiring intervention due to hemodynamic compromise within 30 seconds; or Clinically significant non-sustained VT (NSVT) where the treating clinician has determined that therapeutic intervention is necessary. Exclusion Criteria: * Concurrent participation in any interventional clinical trial that, in the judgment of the investigator, could interfere with the data collection or outcome assessment of this observational study.

Outcomes

Primary Outcomes

Composite of death and recurrence of ventricular tachycardia

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.